Finance 2024 expectations for Wegovy, Ozempic, Zepbound by CoinNews December 17, 2023 by CoinNews December 17, 2023 George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye… Read more 0 FacebookTwitterPinterestEmail
Finance Patients Regain Weight After They Quit Using Ozempic Rival Zepbound. Here’s Why That Makes Eli Lilly Stock an Even Better Buy. by CoinNews December 16, 2023 by CoinNews December 16, 2023 Seemingly bad news can sometimes be really good news. I think a recent study for… Read more 0 FacebookTwitterPinterestEmail
Finance Pfizer’s Latest Ozempic Competitor Just Flopped (Again). Is the Stock Still a Buy? by CoinNews December 8, 2023 by CoinNews December 8, 2023 On Dec. 1, Pfizer (PFE 0.52%) reported some less-than-great news to investors. In short, its… Read more 0 FacebookTwitterPinterestEmail
Finance Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here’s How. by CoinNews November 20, 2023 by CoinNews November 20, 2023 Novo Nordisk‘s (NVO 2.17%) Ozempic is indicated to treat diabetes, and its wild success and… Read more 0 FacebookTwitterPinterestEmail
Finance AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don’t Rush to Buy the Stock by CoinNews November 17, 2023 by CoinNews November 17, 2023 U.K.-based AstraZeneca (AZN 0.52%) is now gearing up for the second time to develop a… Read more 0 FacebookTwitterPinterestEmail
Finance Weight loss drugs Wegovy, Ozempic may be linked to stomach paralysis by CoinNews October 5, 2023 by CoinNews October 5, 2023 Still life of Wegovy an injectable prescription weight loss medicine that has helped people with… Read more 0 FacebookTwitterPinterestEmail
Finance Ozempic Sales Are Soaring — Here's Why They Could Go Even Higher by CoinNews July 6, 2023 by CoinNews July 6, 2023 By 2050, the number of people with diabetes could top 1.3 billion, according to a… Read more 0 FacebookTwitterPinterestEmail